Erratum: Global deletion of MGL in mice delays lipid absorption and alters energy homeostasis and diet-induced obesity (Journal of Lipid Research (2015) 56 (1153-1171) DOI: 10.1194/jlr.M058586);Global deletion of MGL in mice delays lipid absorption and alters energy homeostasis and diet-induced obesity

Journal of Lipid Research

Volumn 56, Issue 6, 2015, Pages 1153-1171

  Douglass, John D ^a,d   Zhou, Yin Xiu ^a   Wu, Amy ^a   Zadrogra, John A ^a   Gajda, Angela M ^a   Lackey, Atreju I ^a   Lang, Wensheng ^c   Chevalier, Kristen M ^c   Sutton, Steven W ^c   Zhang, Sui Po ^c   Flores, Christopher M ^c   Connelly, Margery A ^c,e   Storch, Judith ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e LIPOSCIENCE INC   (United States)

Author keywords

Monoacylglycerol lipase; Monoacylglycerols; Monoglycerides

Indexed keywords

ACYLGLYCEROL LIPASE; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE 1; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE 2; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ENDOCANNABINOID; FAT INTAKE; LIPID; MONOACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY MASS; CONTROLLED STUDY; DIET INDUCED OBESITY; DOWN REGULATION; ENERGY BALANCE; ENERGY EXPENDITURE; FAT CONTENT; FEMALE; FOOD INTAKE; GENE ACTIVITY; GENE EXPRESSION REGULATION; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID ABSORPTION; LIPID TRANSPORT; LIPOGENESIS; LOSS OF FUNCTION MUTATION; MALE; MGL GENE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WEIGHT GAIN; ANIMAL; BLOOD; ENERGY METABOLISM; FAT INTAKE; GENETICS; HOMEOSTASIS; KNOCKOUT MOUSE; LIPID DIET; OBESITY; PATHOLOGY;

ANIMALS; DIET, HIGH-FAT; DIETARY FATS; ENDOCANNABINOIDS; ENERGY METABOLISM; HOMEOSTASIS; LIPIDS; MICE; MICE, KNOCKOUT; MONOACYLGLYCEROL LIPASES; MONOGLYCERIDES; OBESITY; WEIGHT GAIN;

EID: 84937124470     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M058586ERR     Document Type: Erratum

References (77)

1. Phan, C. T., and P. Tso. 2001. Intestinal lipid absorption and transport. Front. Biosci. 6: D299-D319.
2. Labar, G., J. Wouters, and D. M. Lambert. 2010. A review on the monoacylglycerol lipase: at the interface between fat and endocannabinoid signalling. Curr. Med. Chem. 17: 2588-2607.
3. Stella, N., P. Schweitzer, and D. Piomelli. 1997. A second endogenous cannabinoid that modulates long-term potentiation. Nature. 388: 773-778.
4. Fonseca, B. M., M. A. Costa, M. Almada, G. Correia-da-Silva, and N. A. Teixeira. 2013. Endogenous cannabinoids revisited: A biochemistry perspective. Prostaglandins Other Lipid Mediat. 102-103: 13-30.
5. Gao, Y., D. V. Vasilyev, M. B. Goncalves, F. V. Howell, C. Hobbs, M. Reisenberg, R. Shen, M-Y. Zhang, B. W. Strassle, P. Lu, et al. 2010. Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J. Neurosci. 30: 2017-2024.
6. Yen, C-L. E., M-L. Cheong, C. Grueter, P. Zhou, J. Moriwaki, J. S. Wong, B. Hubbard, S. Marmor, and R. V. Farese. 2009. Deficiency of the intestinal enzyme acyl CoA:monoacylglycerol acyltransferase-2 protects mice from metabolic disorders induced by high-fat feeding. Nat. Med. 15: 442-446.
7. Smith, S. J., S. Cases, D. R. Jensen, H. C. Chen, E. Sande, B. Tow, D. A. Sanan, J. Raber, R. H. Eckel, and R. V. Farese. 2000. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat. Genet. 25: 87-90.
8. Long, J. Z., W. Li, L. Booker, J. J. Burston, S. G. Kinsey, J. E. Schlosburg, F. J. Pavón, A. M. Serrano, D. E. Selley, L. H. Parsons, et al. 2009. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat. Chem. Biol. 5: 37-44.
9. Blankman, J. L., G. M. Simon, and B. F. Cravatt. 2007. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem. Biol. 14: 1347-1356.
10. Tornqvist, H., and P. Belfrage. 1976. Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue. J. Biol. Chem. 251: 813-819.
11. Karlsson, M., J. A. Contreras, U. Hellman, H. Tornqvist, and C. Holm. 1997. cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. J. Biol. Chem. 272: 27218-27223.
12. Karlsson, M., K. Reue, Y. R. Xia, A. J. Lusis, D. Langin, H. Tornqvist, and C. Holm. 2001. Exon-intron organization and chromosomal localization of the mouse monoglyceride lipase gene. Gene. 272: 11-18.
13. Chon, S-H., J. D. Douglass, Y. X. Zhou, N. Malik, J. L. Dixon, A. Brinker, L. Quadro, and J. Storch. 2012. Over-expression of monoacylglycerol lipase (MGL) in small intestine alters endocannabinoid levels and whole body energy balance, resulting in obesity. PLoS ONE. 7: e43962.
14. Rindlisbacher, B., M. Reist, and P. Zahler. 1987. Diacylglycerol breakdown in plasma membranes of bovine chromaffin cells is a two-step mechanism mediated by a diacylglycerol lipase and a monoacylglycerol lipase. Biochim. Biophys. Acta. 905: 349-357.
15. Vandevoorde, S., B. Saha, A. Mahadevan, R. K. Razdan, R. G. Pertwee, B. R. Martin, and C. J. Fowler. 2005. Influence of the degree of unsaturation of the acyl side chain upon the interaction of analogues of 1-arachidonoylglycerol with monoacylglycerol lipase and fatty acid amide hydrolase. Biochem. Biophys. Res. Commun. 337: 104-109.
16. Ghafouri, N., G. Tiger, R. K. Razdan, A. Mahadevan, R. G. Pertwee, B. R. Martin, and C. J. Fowler. 2004. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol. Br. J. Pharmacol. 143: 774-784.
17. Dinh, T. P., S. Kathuria, and D. Piomelli. 2004. RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol. Mol. Pharmacol. 66: 1260-1264.
18. Saario, S. M., O. M. H. Salo, T. Nevalainen, A. Poso, J. T. Laitinen, T. Ja¨rvinen, and R. Niemi. 2005. Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. Chem. Biol. 12: 649-656.
19. Chanda, P. K., Y. Gao, L. Mark, J. Btesh, B. W. Strassle, P. Lu, M. J. Piesla, M-Y. Zhang, B. Bingham, A. Uveges, et al. 2010. Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system. Mol. Pharmacol. 78: 996-1003.
20. Di Marzo, V. 2009. The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. Pharmacol. Res. 60: 77-84.
21. Di Marzo, V., and I. Matias. 2005. Endocannabinoid control of food intake and energy balance. Nat. Neurosci. 8: 585-589.
22. Di Marzo, V., S. K. Goparaju, L. Wang, J. Liu, S. Bátkai, Z. Járai, F. Fezza, G. I. Miura, R. D. Palmiter, T. Sugiura, et al. 2001. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature. 410: 822-825.
23. Cota, D., G. Marsicano, B. Lutz, V. Vicennati, G. K. Stalla, R. Pasquali, and U. Pagotto. 2003. Endogenous cannabinoid system as a modulator of food intake. Int. J. Obes. Relat. Metab. Disord. 27: 289-301.
24. Horvath, T. L. 2003. Endocannabinoids and the regulation of body fat: the smoke is clearing. J. Clin. Invest. 112: 323-326.
25. Cota, D., G. Marsicano, M. Tschöp, Y. Grübler, C. Flachskamm, M. Schubert, D. Auer, A. Yassouridis, C. Thöne-Reineke, S. Ortmann, et al. 2003. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J. Clin. Invest. 112: 423-431.
26. Kunos, G., and D. Osei-Hyiaman. 2008. Endocannabinoids and liver disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis. Am. J. Physiol. Gastrointest. Liver Physiol. 294: G1101-G1104.
27. Osei-Hyiaman, D., M. DePetrillo, P. Pacher, J. Liu, S. Radaeva, S. Bátkai, J. Harvey-White, K. Mackie, L. Offertáler, L. Wang, et al. 2005. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J. Clin. Invest. 115: 1298-1305.
28. Kunos, G., D. Osei-Hyiaman, J. Liu, G. Godlewski, and S. Bátkai. 2008. Endocannabinoids and the control of energy homeostasis. J. Biol. Chem. 283: 33021-33025.
29. Burdyga, G., A. Varro, R. Dimaline, D. G. Thompson, and G. J. Dockray. 2010. Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype. Am. J. Physiol. Gastrointest. Liver Physiol. 299: G63-G69.
30. Gómez, R., M. Navarro, M. Trigo, A. Bilbao, I. Del Arco, A. Cippitelli, F. Nava, D. Piomelli, and F. Rodri. 2002. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J. Neurosci. 22: 9612-9617.
31. Kinsey, S. G., J. Z. Long, S. T. O'Neal, R. A. Abdullah, J. L. Poklis, D. L. Boger, B. F. Cravatt, and A. H. Lichtman. 2009. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain. J. Pharmacol. Exp. Ther. 330: 902-910.
32. Schlosburg, J. E., J. L. Blankman, J. Z. Long, D. K. Nomura, B. Pan, S. G. Kinsey, P. T. Nguyen, D. Ramesh, L. Booker, J. J. Burston, et al. 2010. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat. Neurosci. 13: 1113-1119.
33. Zhong, P., B. Pan, X. Gao, J. L. Blankman, B. F. Cravatt, and Q. Liu. 2011. Genetic deletion of monoacylglycerol lipase alters endocannabinoid-mediated retrograde synaptic depression in the cerebellum. J. Physiol. 589: 4847-4855.
34. Pan, B., W. Wang, P. Zhong, J. L. Blankman, B. F. Cravatt, and Q. S. Liu. 2011. Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice. J. Neurosci. 31: 13420-13430.
35. Taschler, U., F. P. W. Radner, C. Heier, R. Schreiber, M. Schweiger, G. Schoiswohl, K. Preiss-Landl, D. Jaeger, B. Reiter, H. C. Koefeler, et al. 2011. Monoglyceride lipase-deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance. J. Biol. Chem. 286: 17467-17477.
36. Ho, S-Y., L. Delgado, and J. Storch. 2002. Monoacylglycerol metabolism in human intestinal Caco-2 cells: evidence for metabolic compartmentation and hydrolysis. J. Biol. Chem. 277: 1816-1823.
37. Chon, S-H., Y. X. Zhou, J. L. Dixon, and J. Storch. 2007. Intestinal monoacylglycerol metabolism: developmental and nutritional regulation of monoacylglycerol lipase and monoacylglycerol acyltransferase. J. Biol. Chem. 282: 33346-33357.
38. Kirkham, T. C., C. M. Williams, F. Fezza, and V. Di Marzo. 2002. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br. J. Pharmacol. 136: 550-557.
39. Zambrowicz, B. P., and G. A. Friedrich. 1998. Comprehensive mammalian genetics: history and future prospects of gene trapping in the mouse. Int. J. Dev. Biol. 42: 1025-1036.
40. McLean, J. A., and G. Tobin. 1987. Animal and Human Calorimetry. Cambridge University Press, Cambridge, UK.
41. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
42. Storch, J., Y. X. Zhou, and W. S. Lagakos. 2008. Metabolism of apical versus basolateral sn-2-monoacylglycerol and fatty acids in rodent small intestine. J. Lipid Res. 49: 1762-1769.
43. Folch, J., M. Less, and S. Stone. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226: 497-509.
44. Dill, M. J., J. Shaw, J. Cramer, and D. K. Sindelar. 2013. 5-HT1A receptor antagonists reduce food intake and body weight by reducing total meals with no conditioned taste aversion. Pharmacol. Biochem. Behav. 112: 1-8.
45. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
46. Douglass, J. D., N. Malik, S-H. Chon, K. Wells, Y. X. Zhou, A. S. Choi, L. B. Joseph, and J. Storch. 2012. Intestinal mucosal triacylglycerol accumulation secondary to decreased lipid secretion in obese and high fat fed mice. Front. Physiol. 3: 25.
47. Matthews, D. R., J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28: 412-419.
48. Nomura, D. K., B. E. Morrison, J. L. Blankman, J. Z. Long, S. G. Kinsey, M. C. G. Marcondes, A. M. Ward, Y. K. Hahn, A. H. Lichtman, B. Conti, et al. 2011. Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science. 334: 809-813.
49. Hildebrandt, A. L., D. M. Kelly-Sullivan, and S. C. Black. 2003. Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice. Eur. J. Pharmacol. 462: 125-132.
50. Ravinet Trillou, C., C. Delgorge, C. Menet, M. Arnone, and P. Soubrié. 2004. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int. J. Obes. Relat. Metab. Disord. 28: 640-648.
51. Johnston, J. M., G. A. Rao, and P. A. Lowe. 1967. The separation of the alpha-glycerophosphate and monoglyceride pathways in the intestinal biosynthesis of triglycerides. Biochim. Biophys. Acta. 137: 578-580.
52. Eckel, R. H., S. M. Grundy, and P. Z. Zimmet. 2010. The metabolic syndrome. Lancet. 375: 181-183.
53. Zhang, L-N., Y. Gamo, R. Sinclair, S. E. Mitchell, D. G. Morgan, J. C. Clapham, and J. R. Speakman. 2012. Effects of chronic oral rimonabant administration on energy budgets of diet-induced obese C57BL/6 mice. Obesity (Silver Spring). 20: 954-962.
54. Di Marzo, V. 2008. The endocannabinoid system in obesity and type 2 diabetes. Diabetologia. 51: 1356-1367.
55. Kozak, K. R., B. C. Crews, J. D. Morrow, L-H. Wang, Y. H. Ma, R. Weinander, P-J. Jakobsson, and L. J. Marnett. 2002. Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. J. Biol. Chem. 277: 44877-44885.
56. Silvestri, C., and V. Di Marzo. 2013. The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. Cell Metab. 17: 475-490.
57. Polheim, D., J. S. David, F. M. Schultz, M. B. Wylie, and J. M. Johnston. 1973. Regulation of triglyceride biosynthesis in adipose and intestinal tissue. J. Lipid Res. 14: 415-421.
58. Lockwood, J. F., J. Cao, P. Burn, and Y. Shi. 2003. Human intestinal monoacylglycerol acyltransferase: differential features in tissue expression and activity. Am. J. Physiol. Endocrinol. Metab. 285: E927-E937.
59. Buhman, K. K., S. J. Smith, S. J. Stone, J. J. Repa, J. S. Wong, F. F. Knapp, B. J. Burri, R. L. Hamilton, N. A. Abumrad, and R. V. Farese. 2002. DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis. J. Biol. Chem. 277: 25474-25479.
60. Nelson, D. W., Y. Gao, N. M. Spencer, T. Banh, and C-L. E. Yen. 2011. Deficiency of MGAT2 increases energy expenditure without high-fat feeding and protects genetically obese mice from excessive weight gain. J. Lipid Res. 52: 1723-1732.
61. Gao, Y., D. W. Nelson, T. Banh, M-I. Yen, and C-L. E. Yen. 2013. Intestine-specific expression of MOGAT2 partially restores metabolic efficiency in Mogat2-deficient mice. J. Lipid Res. 54: 1644-1652.
62. Lee, B., A. M. Fast, J. Zhu, J-X. Cheng, and K. K. Buhman. 2010. Intestine-specific expression of acyl CoA:diacylglycerol acyltransferase 1 reverses resistance to diet-induced hepatic steatosis and obesity in Dgat1-/- mice. J. Lipid Res. 51: 1770-1780.
63. Martínez-Vargas, M., E. Murillo-Rodríguez, R. González-Rivera, A. Landa, M. Méndez-Díaz, O. Prospéro-García, and L. Navarro. 2003. Sleep modulates cannabinoid receptor 1 expression in the pons of rats. Neuroscience. 117: 197-201.
64. Valenti, M., D. Viganò, M. G. Casico, T. Rubino, L. Steardo, D. Parolaro, and V. Di Marzo. 2004. Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain. Cell. Mol. Life Sci. 61: 945-950.
65. Woodhams, S. G., A. Wong, D. A. Barrett, A. J. Bennett, V. Chapman, and S. P. H. Alexander. 2012. Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat. Br. J. Pharmacol. 167: 1609-1619.
66. Kinsey, S. G., L. E. Wise, D. Ramesh, R. Abdullah, D. E. Selley, B. F. Cravatt, and A. H. Lichtman. 2013. Repeated low dose administration of the monoacylglycerol lipase inhibitor JZL184 retains CB1 receptor mediated antinociceptive and gastroprotective effects. J. Pharmacol. Exp. Ther. 345: 492-501.
67. Steppan, C. M., S. T. Bailey, S. Bhat, E. J. Brown, R. R. Banerjee, C. M. Wright, H. R. Patel, R. S. Ahima, and M. A. Lazar. 2001. The hormone resistin links obesity to diabetes. Nature. 409: 307-312.
68. Li, F-P., J. He, Z-Z. Li, Z-F. Luo, L. Yan, and Y. Li. 2009. Effects of resistin expression on glucose metabolism and hepatic insulin resistance. Endocrine. 35: 243-251.
69. Rajala, M. W., S. Obici, P. E. Scherer, and L. Rossetti. 2003. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J. Clin. Invest. 111: 225-230.
70. Qi, Y., Z. Nie, Y-S. Lee, N. S. Singhal, P. E. Scherer, M. A. Lazar, and R. S. Ahima. 2006. Loss of resistin improves glucose homeostasis in leptin deficiency. Diabetes. 55: 3083-3090.
71. Lan, H., H. V. Lin, C. F. Wang, M. J. Wright, S. Xu, L. Kang, K. Juhl, J. A. Hedrick, and T. J. Kowalski. 2012. Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways. Br. J. Pharmacol. 165: 2799-2807.
72. Hansen, K. B., M. M. Rosenkilde, F. K. Knop, N. Wellner, T. A. Diep, J. F. Rehfeld, U. B. Andersen, J. J. Holst, and H. S. Hansen. 2011. 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans. J. Clin. Endocrinol. Metab. 96: E1409-E1417.
73. Nomura, D. K., J. Z. Long, S. Niessen, H. S. Hoover, S-W. Ng, and B. F. Cravatt. 2010. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell. 140: 49-61.
74. Lombardi, D. P., D. K. Nomura, and B. F. Cravatt. 2010. Blockade of monoacylglycerol lipase impairs prostate cancer cell pathogenicity. Clin. Transl. Sci. 3: S46.
75. Cao, Z., M. M. Mulvihill, P. Mukhopadhyay, H. Xu, K. Erdélyi, E. Hao, E. Holovac, G. Haskó, B. F. Cravatt, D. K. Nomura, et al. 2013. Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice. Gastroenterology. 144: 808-817.
76. Chen, R., J. Zhang, Y. Wu, D. Wang, G. Feng, Y-P. Tang, Z. Teng, and C. Chen. 2012. Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease. Cell Reports. 2: 1329-1339.
77. Hotamisligil, G. S. 2006. Inflammation and metabolic disorders. Nature. 444: 860-867.